openPR Logo
Press release

Respiratory Disease Testing Market: Increasing Investments in R&D Initiatives Creates Growth Opportunities for Players

11-22-2017 08:50 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Respiratory Disease Testing Market: Increasing Investments

The presence of large pool of players points towards a high competitive business landscape in the global respiratory disease testing market, states a new study by Transparency Market Research (TMR). The leading companies, such as GE Healthcare, Cosmed, Philips Healthcare, and CareFusion Corp., are actively investing in research activities to accelerate the development of novel and technologically advanced respiratory disease testing devices and solutions. Hitherto, players have been relying upon technology for their growth; however, a shift in their focus is anticipated in the near future towards strategic collaborations to strengthen their positions in this market, reports the study.

Read Report Overview @ https://www.transparencymarketresearch.com/respiratory-disease-testing.html

As per TMR, the opportunity in the worldwide market for respiratory disease testing was US$2.32 bn in 2013. Expanding at a CAGR of 3.40% during the period from 2014 to 2022, the market is likely to reach a value of US$3.1 mn by the end of the forecast period. Respiratory disease testing solutions find significant application in hospitals, clinical laboratories, and physicians’ clinics. Hospitals have emerged as the leading end user of these solutions and are expected to remain so over the next few years. Currently, the demand for imaging test is much higher than other types of tests for the detection of respiratory diseases. Researchers anticipate this trend to continue in the near future.

Regionally, the global respiratory disease testing market reports its presence across the Middle East and Africa, Latin America, Asia Pacific, North America, and Europe. North America led the global market in 2013 and is projected to retain its dominance over the period of the forecast, states the research report.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288

“The significant rise in the prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and cystic fibrosis, is the main factor behind the constant growth of the global market for respiratory disease testing,” states the author of the study. Since early detection of these diseases assist in effective treatment, the demand for respiratory disease testing solutions is continually increasing, reflecting greatly on this market.

The rise in the population of elderly people, prone to respiratory problems, are also supporting the market’s progress remarkably. The technological advancements in these devices and solutions are projected to boost this market in the years to come, reports the study.

Request Respiratory Disease Testing Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1288

In spite of the high demand for respiratory disease testing solutions across the world, the market may face significant challenges from the low adoption rate of portable spirometers and digital radiography among masses over the forthcoming years. The high cost of these testing devices are also projected to create hindrances in the market’s growth trajectory in the near future.

Nonetheless, the increasing governmental support, in terms of funding, for research and development and the escalating number of awareness programs are anticipated to keep the market going over the forecast period, states the report.

Buy Full Respiratory Disease Testing Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1288<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Disease Testing Market: Increasing Investments in R&D Initiatives Creates Growth Opportunities for Players here

News-ID: 827674 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Respiratory

Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables: Key …
The Respiratory Disposables Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Respiratory Disposables Market Size During the Forecast Period? The respiratory disposables market has seen rapid growth in recent years. It is expected to grow from $1.01 billion in 2024 to $1.15
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Molecular Respiratory Panels Market: Enhancing Accuracy and Speed in Respiratory …
Introduction The global molecular respiratory panels market is rapidly evolving, driven by the need for faster, more accurate diagnostics in respiratory diseases. With respiratory infections and diseases becoming increasingly prevalent worldwide, accurate detection and timely diagnosis are critical to improving patient outcomes. Molecular respiratory panels, which utilize advanced molecular techniques like PCR (Polymerase Chain Reaction) and other nucleic acid-based methods, enable the rapid identification of pathogens responsible for respiratory conditions. These
Tackling Respiratory Challenges: Lower Respiratory Tract Therapeutics Market 202 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Lower Respiratory Tract Therapeutics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $48.37 billion In
Respiratory Assist Devices Market - Breathing Uninterrupted: Innovating Respirat …
Newark, New Castle, USA - new report, titled Respiratory Assist Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Respiratory Assist Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Respiratory Assist Devices market. The report offers an overview of